NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal
National Cancer Institute (NCI)
Van K Morris; Kristen K Ciombor; Lianchun Xiao; Joshua K Ochieng; Enrica Marmonti; Blase Polite; Benjamin A Weinberg; John C Krauss; John Hays; Sarbajit Mukherjee; Olivia Aranha; Syma Iqbal; Tony Shields; Al B Benson; Syed Kazmi; Christopher Lieu; Howard Hochster; Jennifer Whisenant; Cara Haymaker; Cathy Eng